Literature DB >> 4037773

Effects of elevation of serum cholesterol and administration of amphotericin B complexed to lipoproteins on amphotericin B-induced toxicity in rabbits.

M H Koldin, G S Kobayashi, J Brajtburg, G Medoff.   

Abstract

Amphotericin B was infused into normal rabbits or rabbits made hypercholesterolemic by diet. There was no difference in amphotericin B-induced toxicity between these two groups. Amphotericin B given in a mixture with human low-density lipoproteins was more toxic than when given without lipoproteins.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4037773      PMCID： PMC176327          DOI： 10.1128/AAC.28.1.144

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  8 in total

1.  Changes in apolipoproteins and properties of rabbit very low density lipoproteins on induction of cholesteremia.

Authors:  V G Shore; B Shore; R G Hart
Journal:  Biochemistry       Date:  1974-04-09       Impact factor: 3.162

2.  Enzymatic determination of total serum cholesterol.

Authors:  C C Allain; L S Poon; C S Chan; W Richmond; P C Fu
Journal:  Clin Chem       Date:  1974-04       Impact factor: 8.327

3.  A pharmacologic guide to the clinical use of amphotericin B.

Authors:  D D Bindschadler; J E Bennett
Journal:  J Infect Dis       Date:  1969-10       Impact factor: 5.226

Review 4.  Antifungal agents useful in therapy of systemic fungal infections.

Authors:  G Medoff; J Brajtburg; G S Kobayashi; J Bolard
Journal:  Annu Rev Pharmacol Toxicol       Date:  1983       Impact factor: 13.820

5.  Treatment and prophylaxis of disseminated infection due to Candida albicans in mice with liposome-encapsulated amphotericin B.

Authors:  G Lopez-Berestein; R Mehta; R L Hopfer; K Mills; L Kasi; K Mehta; V Fainstein; M Luna; E M Hersh; R Juliano
Journal:  J Infect Dis       Date:  1983-05       Impact factor: 5.226

6.  Interaction of plasma proteins and lipoproteins with amphotericin B.

Authors:  J Brajtburg; S Elberg; J Bolard; G S Kobayashi; R A Levy; R E Ostlund; D Schlessinger; G Medoff
Journal:  J Infect Dis       Date:  1984-06       Impact factor: 5.226

7.  Dissociation kinetics and equilibrium binding properties of polyene antibiotic complexes with phosphatidylcholine/sterol vesicles.

Authors:  N M Witzke; R Bittman
Journal:  Biochemistry       Date:  1984-04-10       Impact factor: 3.162

8.  Enhancement of amphotericin B selectivity by antibiotic incorporation into gel state vesicles. A circular dichroism and permeability study.

Authors:  A Vertut-Croquin; J Bolard; C M Gary-Bobo
Journal:  Biochem Biophys Res Commun       Date:  1984-11-30       Impact factor: 3.575
  8 in total
  12 in total

Review 1.  Amphotericin B: delivery systems.

Authors:  J Brajtburg; W G Powderly; G S Kobayashi; G Medoff
Journal:  Antimicrob Agents Chemother       Date:  1990-03       Impact factor: 5.191

2.  Physical characteristics and lipoprotein distribution of liposomal nystatin in human plasma.

Authors:  K M Wasan; M Ramaswamy; S M Cassidy; M Kazemi; F W Strobel; R L Thies
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

Review 3.  Carrier effects on biological activity of amphotericin B.

Authors:  J Brajtburg; J Bolard
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

4.  Rat and rabbit plasma distribution of free and chylomicron-associated BIRT 377, a novel small molecule antagonist of LFA-1-mediated cell adhesion.

Authors:  K M Wasan; M Ramaswamy; L Holtorf; A A Jayaraj; D J Hauss
Journal:  Pharm Res       Date:  2001-04       Impact factor: 4.200

5.  Species differences in the proportion of plasma lipoprotein lipid carried by high-density lipoproteins influence the distribution of free and liposomal nystatin in human, dog, and rat plasma.

Authors:  M Ramaswamy; T L Wallace; P A Cossum; K M Wasan
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

6.  Effect of fasting on temporal variation in the nephrotoxicity of amphotericin B in rats.

Authors:  M LeBrun; L Grenier; M G Bergeron; L Thibault; G Labrecque; D Beauchamp
Journal:  Antimicrob Agents Chemother       Date:  1999-03       Impact factor: 5.191

7.  Amphotericin B incorporated into egg lecithin-bile salt mixed micelles: molecular and cellular aspects relevant to therapeutic efficacy in experimental mycoses.

Authors:  J Brajtburg; S Elberg; G S Kobayashi; J Bolard
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

8.  Roles of liposome composition and temperature in distribution of amphotericin B in serum lipoproteins.

Authors:  K M Wasan; G A Brazeau; A Keyhani; A C Hayman; G Lopez-Berestein
Journal:  Antimicrob Agents Chemother       Date:  1993-02       Impact factor: 5.191

9.  The endocytic process in CHO cells, a toxic pathway of the polyene antibiotic amphotericin B.

Authors:  A Vertut-Doï; S I Ohnishi; J Bolard
Journal:  Antimicrob Agents Chemother       Date:  1994-10       Impact factor: 5.191

10.  Influence of diet on experimental toxicity of amphotericin B deoxycholate.

Authors:  P Chavanet; V Joly; D Rigaud; J Bolard; C Carbon; P Yeni
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.